SMAD proteins in TGF-β signalling pathway in cancer: regulatory mechanisms and clinical applications
Q Wang, F Xiong, G Wu, D Wang, W Liu, J Chen, Y Qi… - Diagnostics, 2023 - mdpi.com
Suppressor of mother against decapentaplegic (SMAD) family proteins are central to one of
the most versatile cytokine signalling pathways in metazoan biology, the transforming …
the most versatile cytokine signalling pathways in metazoan biology, the transforming …
PAF1c links S-phase progression to immune evasion and MYC function in pancreatic carcinoma
A Gaballa, A Gebhardt-Wolf, B Krenz… - Nature …, 2024 - nature.com
In pancreatic ductal adenocarcinoma (PDAC), endogenous MYC is required for S-phase
progression and escape from immune surveillance. Here we show that MYC in PDAC cells …
progression and escape from immune surveillance. Here we show that MYC in PDAC cells …
Exploring the molecular mechanisms and therapeutic potential of SMAD4 in colorectal cancer
H Shan, G Tian, Y Zhang, Z Qiu - Cancer Biology & Therapy, 2024 - Taylor & Francis
Colorectal Cancer (CRC) is the third most common cancer worldwide, and the occurrence
and development of CRC are influenced by the molecular biology characteristics of CRC …
and development of CRC are influenced by the molecular biology characteristics of CRC …
Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/ERK signalling pathway
C Ma, M Liu, W Feng, H Rao, W Zhang… - Clinical and …, 2023 - Wiley Online Library
Backgound Colorectal cancer (CRC) is a complex, multistep disease that arises from the
interplay genetic mutations and epigenetic alterations. The histone H3K36 …
interplay genetic mutations and epigenetic alterations. The histone H3K36 …
KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma
Y Wang, S Liu, Y Wang, B Li, J Liang, Y Chen… - Cell Death …, 2024 - nature.com
Inactivated suppressor of mothers against decapentaplegic homolog (SMAD) 4 significantly
affects cancer development in pancreatic ductal adenocarcinoma (PDAC). However, the …
affects cancer development in pancreatic ductal adenocarcinoma (PDAC). However, the …
CircLDLRAD3 inhibits Oral squamous cell carcinoma progression by regulating miR‐558/Smad4/TGF‐β
X Zhang, GY Guo, RY Liu, T Wu… - Journal of Cellular …, 2023 - Wiley Online Library
Oral squamous cell carcinoma (OSCC) is a malignant neoplasm with high mortality and
morbidity. The role of circRNA and its molecular mechanism in OSCC remains largely …
morbidity. The role of circRNA and its molecular mechanism in OSCC remains largely …
[HTML][HTML] Synergistic Enhancement of 5-Fluorouracil Chemotherapeutic Efficacy by Taurine in Colon Cancer Rat Model
DH Jornada, D Boreski, DE Chiba, D Ligeiro, MAM Luz… - Nutrients, 2024 - mdpi.com
Colorectal cancer (CRC) is one of the top 10 most common cancers worldwide and caused
approximately 10 million deaths in 2022. CRC mortality has increased by 10% since 2020 …
approximately 10 million deaths in 2022. CRC mortality has increased by 10% since 2020 …
Regulation of mitochondrial quality control of intestinal stem cells in homeostasis and diseases
X Lei, Z Xu, Y Huang, L Huang, J Lang… - Antioxidants & Redox …, 2024 - liebertpub.com
Significance: Intestinal stem cells (ISCs) are crucial for the continuous renewal and
regeneration of the small intestinal epithelium. ISC fate decisions are strictly controlled by …
regeneration of the small intestinal epithelium. ISC fate decisions are strictly controlled by …
Nidogen-1/NID1 Function and Regulation during Progression and Metastasis of Colorectal Cancer
M Rokavec, S Jaeckel, H Hermeking - Cancers, 2023 - mdpi.com
Simple Summary Nidogen1 (NID1) is a component of the extracellular matrix and basement
membranes. NID1 represents a linker between laminins, collagens, proteoglycans and cell …
membranes. NID1 represents a linker between laminins, collagens, proteoglycans and cell …
Implications of c-Myc in the Pathogenesis and Treatment Efficacy of Urological Cancers
Urological cancers, including prostate, bladder, and renal cancers, are significant causes of
death and negatively impact the quality of life for patients. The development and progression …
death and negatively impact the quality of life for patients. The development and progression …